山东大学教师主页窦蕾论文成果中文主页

j6p ySr VR8 9qg m2o rX8 SHW tmH sKs TtK Xu2 mKg VDG O93 MqT Y3B HYO Hk7 kd3 vJd

论文成果

[1] 徐艳娇. 基于欧洲五维度五水平健康量表和中文版低视力者生活质量量表测量老年性黄斑变性患者健康相关生命质量. 《中国药物经济学》, 18, 5-9,15, 2023.
[2] 刘世贤. 国内外药物经济学评价研究的文献计量及可视化分析. 《中国医院药学杂志》, 41, 1-10, 2021.
[3] 刘世贤. Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma. FRONTIERS IN ONCOLOGY, 12, 899966, 2022.
[4] 刘世贤. 替雷利珠单抗二线治疗晚期或转移性食管鳞状细胞癌的成本-效用分析. 《中国药房》, 33, 2250-2255, 2022.
[5] 王凯旋. 健康效用值在药物经济学评价模型中应用的规范性评价指标体系构建研究. 世界临床药物, 43, 1299-1306, 2022.
[6] . Correlation between disease activity and patient-reported health-related quality of life in rheumatoid arthritis: a cross-sectional study. BMJ Open, 14, 1, 2024.
[7] 刘世贤. Immune checkpoint inhibitors versus chemotherapy as second-line therapy for advanced oesophageal squamous cell carcinoma: a systematic review and economic evaluation. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 17, 2024.
[8] 窦蕾. Health-related quality of life and its changes of the Tibetan population in China based on the 2013 and 2018 National Health Services Surveys. BMJ Open, 13, 1, 2023.
[9] 李超凡. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease. Health and Quality of Life Outcomes, 21, 2023.
[10] 刘世贤. Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China. FRONT PHARMACOL, 14, 2023.

共 30 条 1/3

首页上一页下一页尾页页

窦蕾

助理研究员

性别：女

在职信息：在职

所在单位：公共卫生学院

入职时间： 2016-01-06

所属院系：齐鲁医学院

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..